An Open Letter To Gwyneth Paltrow About GOOP
Dear Ms. Paltrow,
I understand you recently said that anyone who is going to f*ck with you better bring their A game.
I’m pretty sure you don’t mean comment on your recipes but rather the growing exasperation from medical professionals and journalists alike at the almost constant debunking of the health “advice” and all around medical bullshit that you and your pals at GOOP promote and sell. No, we don’t have adrenal fatigue we have goopitis.
When I tell you that alcohol is a toxin I am not f*cking with you I am being factual. Do you really think everything in the world is a toxin exce...
Source: Healthy Living - The Huffington Post - June 1, 2017 Category: Consumer Health News Source Type: news
The scariest superbug on the CDC's radar has hit 7 states
The spread of Candida auris started in New York and New Jersey - but in the last month, new infections have been spotted in Illinois, Indiana, Maryland, Massachusetts and Oklahoma. (Source: the Mail online | Health)
Source: the Mail online | Health - May 19, 2017 Category: Consumer Health News Source Type: news
Candida Auris, Often Drug-Resistant, Found in 7 States (FREE)
By Amy Orciari Herman
Edited by Andr é Sofair, MD, MPH, and William E. Chavey, MD, MS
As of mid-May 2017, a total of 77 clinical cases of Candida auris in U.S. health care facilities were reported to the CDC, according to … (Source: Physician's First Watch current issue)
Source: Physician's First Watch current issue - May 19, 2017 Category: Primary Care Source Type: news
Notes from the Field: Ongoing Transmission of Candida auris in Health Care Facilities — United States, June 2016–May 2017
(Source: CDC Morbidity and Mortality Weekly Report)
Source: CDC Morbidity and Mortality Weekly Report - May 18, 2017 Category: American Health Source Type: news
Candida auris: Emerging, Frequently Resistant, and Often Deadly Candida auris: Emerging, Frequently Resistant, and Often Deadly
Given frequent multidrug resistance, what drug therapy is appropriate for treating Candida auris?Medscape Pharmacists (Source: Medscape Today Headlines)
Source: Medscape Today Headlines - May 17, 2017 Category: Consumer Health News Tags: Pharmacist Ask the Expert Source Type: news
'Superbug' Fungus Outbreak in NY, NJ Hospitals
NEW YORK (AP) — A 'superbug' fungus is emerging as a new menace in U.S. hospitals, mostly in New York and New Jersey.
First identified in Japan in 2009, the fungus has spread to more than a dozen countries around the globe. The oldest of the 66 cases reported in the U.S. dates back to 2013, but most were reported in the last year.
The fungus called Candida auris is a harmful form of yeast. Scientists say it can be hard to identify with standard lab tests. U.S. health officials sounded alarms last year because two of the three kinds of commonly used antifungal drugs have little effect.
"It's acting like a superbug&qu...
Source: JEMS Patient Care - April 28, 2017 Category: Emergency Medicine Authors: Mike Stobbe, Â AP Medical Writer Tags: News Patient Care Source Type: news
'Superbug' Fungus Outbreak in NY, NJ Hospitals
NEW YORK (AP) — A 'superbug' fungus is emerging as a new menace in U.S. hospitals, mostly in New York and New Jersey.
First identified in Japan in 2009, the fungus has spread to more than a dozen countries around the globe. The oldest of the 66 cases reported in the U.S. dates back to 2013, but most were reported in the last year.
The fungus called Candida auris is a harmful form of yeast. Scientists say it can be hard to identify with standard lab tests. U.S. health officials sounded alarms last year because two of the three kinds of commonly used antifungal drugs have little effect.
"It's acting like a superbug&qu...
Source: JEMS: Journal of Emergency Medical Services News - April 28, 2017 Category: Emergency Medicine Authors: Mike Stobbe, Â AP Medical Writer Tags: News Patient Care Source Type: news
The scariest superbug on CDC's radar is a deadly fungus
Public health officials have revealed that a superbug - Candida auris, a harmful yeast - is on the CDC's radar after spreading to US hospitals, particularly in New York and New Jersey. (Source: the Mail online | Health)
Source: the Mail online | Health - April 26, 2017 Category: Consumer Health News Source Type: news
Your NEJM Group Today: Candida Esophagitis Images / New Approach to Hot Flashes? / FDA Medical Officer Opportunities (FREE)
By the Editors
Here ' s what we chose for you from NEJM Group today:NEJM Clinical Practice Center: Image in Clinical Medicine: A 72-year-old man who … (Source: Physician's First Watch current issue)
Source: Physician's First Watch current issue - April 26, 2017 Category: Primary Care Source Type: news
Antifungal peptides: a potential new class of antifungals for treating vulvovaginal candidiasis caused by fluconazole-resistant Candida albicans.
Vulvovaginal candidiasis/candidosis is a common fungal infection afflicting approximately 75% of women globally caused primarily by the yeast Candida albicans. Fluconazole is widely regarded as the antifungal drug of choice since its introduction in 1990 due to its high oral bioavailability, convenient dosing regimen and favourable safety profile. However, its widespread use has led to the emergence of fluconazole-resistant C. albicans, posing a universal clinical concern. (Source: The Aspergillus Website - updates)
Source: The Aspergillus Website - updates - April 24, 2017 Category: Respiratory Medicine Authors: GAtherton Source Type: news
Candin (Candida Albicans) - updated on RxList
(Source: RxList - New and Updated Drug Monographs)
Source: RxList - New and Updated Drug Monographs - April 11, 2017 Category: Drugs & Pharmacology Source Type: news
Candida auris Further Differentiated: Possible Therapies? Candida auris Further Differentiated: Possible Therapies?
The emerging C auris fungal pathogen is often multidrug resistant and hard to eradicate, but early data suggest it may respond to a new experimental drug.Medscape Medical News (Source: Medscape Medical News Headlines)
Source: Medscape Medical News Headlines - March 31, 2017 Category: Consumer Health News Tags: Infectious Diseases News Source Type: news
Preclinical Pharmacokinetics and Pharmacodynamic Target of SCY-078, a First-in-Class Orally Active Antifungal Glucan Synthesis Inhibitor, in Murine Models of Disseminated Candidiasis.
SCY-078 (MK-3118) is a novel, semisynthetic derivative of enfumafungin and represents the first compound of the triterpene class of antifungals. SCY-078 exhibits potent inhibition of β-(1,3)-d-glucan synthesis, an essential cell wall component of many pathogenic fungi, including Candida spp. and Aspergillus spp. SCY-078 is currently in phase 2 clinical development for the treatment of invasive fungal diseases. In vitro disposition studies to assess solubility, intestinal permea bility, and metabolic stability were predictive of good oral bioavailability. (Source: The Aspergillus Website - updates)
Source: The Aspergillus Website - updates - March 27, 2017 Category: Respiratory Medicine Authors: GAtherton Source Type: news
Pharmacokinetics of the Novel Echinocandin, CD101, in Multiple Animal Species.
CD101 is a novel semisynthetic echinocandin with antifungal activity against Candida and Aspergillus spp. The pharmacokinetics (PK) of CD101 administered intravenously to mice, rats, dogs, cynomolgus monkeys, and chimpanzees are presented. CD101 consistently exhibited very low clearance, a modest volume of distribution at steady state (Vss), and a long half-life (t1/2) across all species tested. (Source: The Aspergillus Website - updates)
Source: The Aspergillus Website - updates - March 27, 2017 Category: Respiratory Medicine Authors: GAtherton Source Type: news
Drug-Resistant Fungus Spreads Among U.S. Healthcare Facilities
This article was updated from a Nov. 2016 story on C. auris.
This reporting is brought to you by HuffPost’s health and science platform, The Scope. Like us on Facebook and Twitter and tell us your story: scopestories@huffingtonpost.com.
-- This feed and its contents are the property of The Huffington Post, and use is subject to our terms. It may be used for personal consumption, but may not be distributed on a website. (Source: Healthy Living - The Huffington Post)
Source: Healthy Living - The Huffington Post - March 21, 2017 Category: Consumer Health News Source Type: news
